- NOVO_B: Medicare will temporarily cover Wegovy under an 18-month GLP-1 Bridge from July 1 with prior auth and $50 copay; applies to beneficiaries meeting BMI/medical criteria; program ends Dec 2027.
- NOVO_B signed an outsourcing deal with Shantha Biologics for cartridge fill–finish manufacturing in India, naming Shantha as the contract manufacturer for those production tasks.
TradingView
Key facts: Medicare to temporarily cover Wegovy; Novo appoints Shantha
NOVO_B: Medicare will temporarily cover Wegovy under an 18-month GLP-1 Bridge from July 1 with prior auth and $50 copay; applies to beneficiaries meeting BMI/medical criteria; prog